AU2005322873B2 - Adipose-derived stem cells for tissue regeneration and wound healing - Google Patents

Adipose-derived stem cells for tissue regeneration and wound healing Download PDF

Info

Publication number
AU2005322873B2
AU2005322873B2 AU2005322873A AU2005322873A AU2005322873B2 AU 2005322873 B2 AU2005322873 B2 AU 2005322873B2 AU 2005322873 A AU2005322873 A AU 2005322873A AU 2005322873 A AU2005322873 A AU 2005322873A AU 2005322873 B2 AU2005322873 B2 AU 2005322873B2
Authority
AU
Australia
Prior art keywords
cells
adsc
adipose
tissue
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005322873A
Other languages
English (en)
Other versions
AU2005322873A1 (en
Inventor
Chauncey B. Sayre
Francisco J. Silva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PrimeGen Biotech LLC
Original Assignee
PrimeGen Biotech LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PrimeGen Biotech LLC filed Critical PrimeGen Biotech LLC
Publication of AU2005322873A1 publication Critical patent/AU2005322873A1/en
Application granted granted Critical
Publication of AU2005322873B2 publication Critical patent/AU2005322873B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2005322873A 2004-12-30 2005-12-30 Adipose-derived stem cells for tissue regeneration and wound healing Ceased AU2005322873B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64103404P 2004-12-30 2004-12-30
US60/641,034 2004-12-30
PCT/US2005/047437 WO2006074075A2 (en) 2004-12-30 2005-12-30 Adipose-derived stem cells for tissue regeneration and wound healing

Publications (2)

Publication Number Publication Date
AU2005322873A1 AU2005322873A1 (en) 2006-07-13
AU2005322873B2 true AU2005322873B2 (en) 2011-09-01

Family

ID=36588983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005322873A Ceased AU2005322873B2 (en) 2004-12-30 2005-12-30 Adipose-derived stem cells for tissue regeneration and wound healing

Country Status (6)

Country Link
US (1) US8119398B2 (OSRAM)
EP (1) EP1830862B1 (OSRAM)
JP (1) JP2008526762A (OSRAM)
AU (1) AU2005322873B2 (OSRAM)
CA (1) CA2592840C (OSRAM)
WO (1) WO2006074075A2 (OSRAM)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9144583B2 (en) 2002-03-29 2015-09-29 Tissue Genesis, Inc. Cell separation apparatus and methods of use
WO2005035738A1 (en) * 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells
US20140193852A9 (en) * 2004-12-23 2014-07-10 Erik Vossman Adipose tissue collection and pre-processing devices for use in liposuction procedure
CA2660661A1 (en) * 2005-09-26 2007-04-05 The Trustees Of Columbia University In The City Of New York Side population cells in cardiac repair
WO2007089798A2 (en) * 2006-01-30 2007-08-09 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
WO2008106410A1 (en) 2007-02-26 2008-09-04 Cvac Systems, Inc. Combination pressure therapy for treatment of serum lipid levels, steroid levels, and steroidogenesis
US8899228B2 (en) 2006-02-08 2014-12-02 Cvac Systems, Inc. Combination pressure therapy for treatment of chronic pain
CN101473030A (zh) * 2006-06-15 2009-07-01 Rnl生物技术株式会社 含有来自人类脂肪组织的多塑性干细胞、成纤维细胞和脂肪或脂肪细胞的整容或整形组合物
WO2008018450A1 (en) * 2006-08-08 2008-02-14 National University Corporation Nagoya University Cell preparation containing multipotential stem cells originating in fat tissue
JP2010505849A (ja) * 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性創傷治癒に有用な方法および組成物
US11174458B2 (en) 2007-04-23 2021-11-16 Koligo Therapeutics, Inc. Cell separation apparatus and methods of use
US20100291042A1 (en) 2007-05-03 2010-11-18 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
JP5340564B2 (ja) * 2007-07-05 2013-11-13 ライオン株式会社 人工皮膚およびその製造方法
KR101738323B1 (ko) 2007-09-19 2017-05-19 플루리스템 리미티드 지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
AU2009244308A1 (en) * 2008-05-06 2009-11-12 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
WO2009152084A2 (en) 2008-06-11 2009-12-17 Cell4Vet Llc Adipose tissue-derived stem cells for veterinary use
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
US20110208162A1 (en) * 2008-10-24 2011-08-25 Indiana University Rsearch and Technology Corporation Methods for preventing aggregation of adipose stromal cells
MX2011011114A (es) * 2009-04-20 2012-04-02 Univ Indiana Res & Tech Corp Materiales y metodos para utilizar celulas madre de tejido adiposo para tratar una lesion y enfermedad pulmonar.
WO2010129775A1 (en) 2009-05-06 2010-11-11 University Of Virginia Patent Foundation Self-illuminated handheld lens for retinal examination and photography and related method thereof
KR100995133B1 (ko) * 2010-02-10 2010-11-18 허쉬바이오주식회사 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
TWI419970B (zh) * 2010-11-11 2013-12-21 Univ Nat Taiwan 使成體幹細胞產生為一球體細胞群體的方法
WO2012154301A1 (en) * 2011-03-18 2012-11-15 Tornier, Inc. Allogeneic microvascular tissue for soft tissue treatments
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
US9512405B2 (en) 2011-12-14 2016-12-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Non-enzymatic method for isolating human adipose-derived stromal stem cells
US20140074068A1 (en) * 2012-09-12 2014-03-13 Richard Ty Olmstead Multi-component method for regenerative repair of wounds implementing photonic wound debridement and stem cell deposition
US9872937B2 (en) 2012-09-19 2018-01-23 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US11819522B2 (en) 2012-09-19 2023-11-21 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US10596202B2 (en) 2012-09-19 2020-03-24 Microvascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
EP3476410B1 (en) * 2012-09-19 2021-08-18 MicroVascular Tissues, Inc. Compositions and methods for treating and preventing tissue injury and disease
US9650608B2 (en) 2013-02-22 2017-05-16 Medivet America, Llc Activating adipose-derived stem cells for transplantation
US9782469B2 (en) 2013-04-19 2017-10-10 Changwon National University Industry Academy Cooperation Corps Anti-inflammatory, skin-regenerative, whitening, antioxidant, or wound-healing composition containing culture medium of ADSC-T cells in which T-antigen is introduced into adipose-derived stem cell as active ingredient
KR101527880B1 (ko) * 2013-04-19 2015-06-10 창원대학교 산학협력단 지방유래줄기세포에 t 항원을 도입한 adsc-t 세포의 배양액을 유효성분으로 포함하는, 피부재생용, 미백용, 항산화용 또는 상처 치료용 조성물
US10131880B2 (en) 2013-05-22 2018-11-20 The Regents Of The University Of California Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications
EP3027235A1 (en) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US20170296697A1 (en) * 2014-10-03 2017-10-19 Cytori Therapeutics, Inc. Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
US20170258841A1 (en) * 2016-03-11 2017-09-14 Gwo Xi Stem Cell Applied Technology Co., Ltd. Pharmaceutical compositions for treating arrhythmia and therapeutics of
KR102017386B1 (ko) * 2017-11-01 2019-09-02 연세대학교 산학협력단 이식된 지방세포의 생착 증진용 조성물 및 지방 이식용 세포 치료제 조성물
IL306070A (en) 2018-05-03 2023-11-01 Collplant Ltd Dermal fillers and their uses
US20230346842A1 (en) * 2020-05-07 2023-11-02 Primegen Biotech, Llc Methods and Compositions For Reducing Joint Inflammation Using Mesenchymal Stem Cells
EP3909593A1 (en) 2020-05-15 2021-11-17 Rigshospitalet Stem cells for treating skin lesions
US20260007720A1 (en) * 2022-07-08 2026-01-08 Trustees Of Tufts College Tissue regenerative multi-drug cocktail and apparatus for delivery thereof
CN119491021B (zh) * 2024-11-13 2025-06-20 中南大学 过表达LncRNA SNHG16慢病毒载体在修复工程材料中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003022988A2 (en) * 2001-09-10 2003-03-20 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20040171146A1 (en) * 1999-03-10 2004-09-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4792525A (en) 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4988621A (en) 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
US4879237A (en) 1985-05-24 1989-11-07 La Jolla Cancer Research Foundation Use of peptides in control of cell attachment and detachment
US4789734A (en) 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
WO1991010470A1 (en) 1990-01-08 1991-07-25 Brown University Research Foundation Devices and methods for enhanced delivery of active factors
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
JPH05112456A (ja) * 1991-10-22 1993-05-07 Osaka Gas Co Ltd ゲル状軟膏
US5965997A (en) 1997-08-20 1999-10-12 Benchmarq Microelectronics Battery monitoring circuit with storage of charge and discharge accumulation values accessible therefrom
IL145002A0 (en) 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
EP1212404A2 (en) * 1999-09-14 2002-06-12 Children's Medical Center Corporation Isolation of muscle-derived stem cells and uses therefore
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
KR100811995B1 (ko) 2001-12-07 2008-03-10 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
KR101310578B1 (ko) 2003-02-20 2013-09-23 사이토리 테라퓨틱스, 인크. 심혈관 증상의 치료에 지방조직-유래 세포를 사용하는 방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171146A1 (en) * 1999-03-10 2004-09-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices
WO2003022988A2 (en) * 2001-09-10 2003-03-20 The Regents Of The University Of California Adipose-derived stem cells and lattices

Also Published As

Publication number Publication date
EP1830862A2 (en) 2007-09-12
AU2005322873A1 (en) 2006-07-13
EP1830862B1 (en) 2012-12-19
US20060147430A1 (en) 2006-07-06
US8119398B2 (en) 2012-02-21
CA2592840C (en) 2015-11-24
CA2592840A1 (en) 2006-07-13
WO2006074075A2 (en) 2006-07-13
WO2006074075A3 (en) 2006-10-12
JP2008526762A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
EP1830862B1 (en) Adipose-derived stem cells for tissue regeneration and wound healing
US8835170B2 (en) Methods and compositions useful for diabetic wound healing
Lazarus et al. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
US9598673B2 (en) Treatment of disc degenerative disease
Azari et al. Effects of transplanted mesenchymal stem cells isolated from Wharton’s jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation
JP2022024047A (ja) 線維芽細胞治療活性を増強する方法
JP5937210B2 (ja) 臍帯組織由来細胞を用いた末梢血管疾患の治療
JP2019088302A (ja) 単離された椎間板細胞、その使用方法、および哺乳動物組織からそれを調製する方法
US20030125293A1 (en) Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
WO2015004609A2 (en) Adherent cells from placenta and use thereof in treatment of injured tendons
US20100040584A1 (en) Methods for promoting neovascularization
JP2021105041A (ja) 熱傷の進行の緩和ならびに皮膚移植片の取り込みおよび治癒の改善における再生細胞の使用
EP2709636A2 (en) Use of mesenchymal stem cells for the improvement of affective and cognitive function
AU2015284180B2 (en) Gonad-derived side population stem cells
US20120201786A1 (en) Methods for the use of stem cells and stem cell factors in the treatment of skin conditions
WO2008063753A1 (en) Endothelial progenitor cell compositions and neovascularization
KR20110032513A (ko) 조직 재생용 조성물
US20220313741A1 (en) Pluripotent stem cells inducing osteochondral repair
Fukuta et al. Synergistic effect of ex-vivo quality and quantity cultured mononuclear cells and mesenchymal stem cell therapy in ischemic hind limb model mice
US20260078333A1 (en) Method of isolating animal gonadal mesenchymal stem cells
US20130287745A1 (en) Compositions and methods to stimulate vascular structure formation
Zhang Optimization of Feline Adipose-Derived Multipotent Stromal Cell Isolation and Canine Cranial Cruciate Ligament Regeneration with Intra-Articular Adipose-Derived Multipotent Stromal Cells
JP2016135791A (ja) 臍帯組織由来細胞を用いた末梢血管疾患の治療

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired